应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
06998 嘉和生物-B
已收盘 03-26 16:08:55
2.170
-0.010
-0.46%
最高
2.170
最低
2.150
成交量
16.95万
今开
2.170
昨收
2.180
日振幅
0.92%
总市值
11.28亿
流通市值
11.28亿
总股本
5.20亿
成交额
36.61万
换手率
0.03%
流通股本
5.20亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
嘉和生物-B03月06日主力净流入0万元 散户资金抛售
市场透视 · 03-06
嘉和生物-B03月06日主力净流入0万元 散户资金抛售
嘉和生物-B盘中异动 快速下挫5.08%
市场透视 · 03-04
嘉和生物-B盘中异动 快速下挫5.08%
嘉和生物-B盘中异动 股价大跌5.61%报2.020港元
市场透视 · 02-28
嘉和生物-B盘中异动 股价大跌5.61%报2.020港元
嘉和生物-B盘中异动 股价大涨5.10%报2.060港元
市场透视 · 02-26
嘉和生物-B盘中异动 股价大涨5.10%报2.060港元
嘉和生物-B盘中异动 下午盘股价大涨5.00%
市场透视 · 02-21
嘉和生物-B盘中异动 下午盘股价大涨5.00%
嘉和生物-B盘中异动 下午盘大幅上涨5.33%报1.780港元
市场透视 · 02-19
嘉和生物-B盘中异动 下午盘大幅上涨5.33%报1.780港元
嘉和生物-B盘中异动 下午盘股价大涨5.39%
市场透视 · 02-14
嘉和生物-B盘中异动 下午盘股价大涨5.39%
困境中的转机——嘉和生物与亿腾医药合并
新浪财经 · 02-14
困境中的转机——嘉和生物与亿腾医药合并
异动解读 | 嘉和生物-B拟更换核数师 股价盘中大跌5.35%
异动解读 · 01-23
异动解读 | 嘉和生物-B拟更换核数师 股价盘中大跌5.35%
嘉和生物-B盘中异动 急速下跌5.35%报1.770港元
市场透视 · 01-23
嘉和生物-B盘中异动 急速下跌5.35%报1.770港元
嘉和生物(06998.HK)拟罢免罗兵咸永道 改聘安永为新核数师
阿斯达克财经 · 01-23
嘉和生物(06998.HK)拟罢免罗兵咸永道 改聘安永为新核数师
嘉和生物-B拟委任安永为新核数师
格隆汇 · 01-22
嘉和生物-B拟委任安永为新核数师
【嘉和生物-B:拟委任安永为新核数师】嘉和生物-B公告,公司拟于公司将召开及举行的股东特别大会上通过相关决议案后罢免罗兵咸永道会计师事务所的公司核数师一职。董事会提议委任安永会计师事务所为公司的新核数师,以填补因建议罢免而产生的临时空缺,任期至公司下届股东周年大会结束为止。
金融界 · 01-22
【嘉和生物-B:拟委任安永为新核数师】嘉和生物-B公告,公司拟于公司将召开及举行的股东特别大会上通过相关决议案后罢免罗兵咸永道会计师事务所的公司核数师一职。董事会提议委任安永会计师事务所为公司的新核数师,以填补因建议罢免而产生的临时空缺,任期至公司下届股东周年大会结束为止。
【嘉和生物-B(06998.HK)拟委任安永会计师事务所为新核数师】嘉和生物-B(06998.HK)发布公告,公司拟于公司将召开及举行的股东特别大会上通过相关决议案后罢免罗兵咸永道会计师事务所的公司核数师一职。
金融界 · 01-22
【嘉和生物-B(06998.HK)拟委任安永会计师事务所为新核数师】嘉和生物-B(06998.HK)发布公告,公司拟于公司将召开及举行的股东特别大会上通过相关决议案后罢免罗兵咸永道会计师事务所的公司核数师一职。
嘉和生物-B(06998)拟委任安永会计师事务所为新核数师
智通财经 · 01-22
嘉和生物-B(06998)拟委任安永会计师事务所为新核数师
嘉和生物-B盘中异动 下午盘股价大涨5.41%报1.950港元
市场透视 · 01-09
嘉和生物-B盘中异动 下午盘股价大涨5.41%报1.950港元
异动解读 | 嘉和生物-B(06998)盘中大涨逾9% 公司与亿腾医药达成反向合并协议
异动解读 · 01-02
异动解读 | 嘉和生物-B(06998)盘中大涨逾9% 公司与亿腾医药达成反向合并协议
港股异动 | 嘉和生物-B(06998)逆市涨近10% 近日与亿腾医药宣布达成战略合并协议
智通财经 · 01-02
港股异动 | 嘉和生物-B(06998)逆市涨近10% 近日与亿腾医药宣布达成战略合并协议
嘉和生物-B盘中异动 股价大涨5.20%
市场透视 · 01-02
嘉和生物-B盘中异动 股价大涨5.20%
加载更多
公司概况
公司名称:
嘉和生物-B
所属市场:
SEHK
上市日期:
--
主营业务:
嘉和生物药业(开曼)控股有限公司是一家主要从事生物制药产品研发的中国公司。该公司专注于开发及商业化肿瘤学及自身免疫性疾病。该公司的主要的药物包括lerociclib(GB491)、coprelotamab(GB221)、geptanolimab(GB226)、GB492、GB242以及GB223。该公司主要于中国市场开展业务。
发行价格:
--
{"stockData":{"symbol":"06998","market":"HK","secType":"STK","nameCN":"嘉和生物-B","latestPrice":2.17,"timestamp":1742976535022,"preClose":2.18,"halted":0,"volume":169500,"delay":0,"floatShares":520000000,"shares":520000000,"eps":-1.4238429249442117,"marketStatus":"已收盘","change":-0.01,"latestTime":"03-26 16:08:55","open":2.17,"high":2.17,"low":2.15,"amount":366070,"amplitude":0.009174,"askPrice":2.19,"askSize":2000,"bidPrice":2.17,"bidSize":17000,"shortable":0,"etf":0,"ttmEps":-1.1097080860113053,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1743039000000},"marketStatusCode":5,"adr":0,"listingDate":1602000000000,"exchange":"SEHK","adjPreClose":2.18,"openAndCloseTimeList":[[1742952600000,1742961600000],[1742965200000,1742976000000]],"volumeRatio":0.182808,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/06998","defaultTab":"news","newsList":[{"id":"2517139874","title":"嘉和生物-B03月06日主力净流入0万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2517139874","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517139874?lang=zh_cn&edition=full","pubTime":"2025-03-06 16:17","pubTimestamp":1741249060,"startTime":"0","endTime":"0","summary":"03月06日, 嘉和生物-B股价涨1.56%,报收1.95元,成交金额136万元,换手率0.13%,振幅5.21%,量比1.02。该股近5个交易日下跌7.48%,主力资金累计净流入0万元;近20日主力资金累计净流入102万元,其中净流入天数为4日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306170451a2622ddd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306170451a2622ddd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","BK1583","BK1161","06998"],"gpt_icon":0},{"id":"2516369265","title":"嘉和生物-B盘中异动 快速下挫5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516369265","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2516369265?lang=zh_cn&edition=full","pubTime":"2025-03-04 10:07","pubTimestamp":1741054069,"startTime":"0","endTime":"0","summary":"2025年03月04日早盘10时07分,嘉和生物-B股票出现异动,股价大幅下挫5.08%。截至发稿,该股报1.870港元/股,成交量23.9万股,换手率0.05%,振幅2.54%。嘉和生物-B股票所在的生物技术行业中,整体跌幅为1.62%。其相关个股中,荃信生物-B、和誉-B、科笛-B涨幅较大,振幅较大的相关个股有科笛-B、北海康成-B、同源康医药-B,振幅分别为12.21%、12.14%、11.43%。嘉和生物-B公司简介:嘉和生物药业曼(开曼)控股有限公司是一家主要从事生物制药业务的公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304100749963862a2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304100749963862a2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","06998","BK1161","BK1583"],"gpt_icon":0},{"id":"2514369017","title":"嘉和生物-B盘中异动 股价大跌5.61%报2.020港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514369017","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514369017?lang=zh_cn&edition=full","pubTime":"2025-02-28 09:42","pubTimestamp":1740706928,"startTime":"0","endTime":"0","summary":"2025年02月28日早盘09时42分,嘉和生物-B股票出现波动,股价快速下挫5.61%。截至发稿,该股报2.020港元/股,成交量12.1万股,换手率0.02%,振幅5.14%。资金方面,该股资金流入5325港元,流出23.801万港元。嘉和生物-B股票所在的生物技术行业中,整体涨幅为1.61%。嘉和生物-B公司简介:嘉和生物药业曼(开曼)控股有限公司是一家主要从事生物制药业务的公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022809420898959cba&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022809420898959cba&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1583","06998","BK1574"],"gpt_icon":0},{"id":"2514008111","title":"嘉和生物-B盘中异动 股价大涨5.10%报2.060港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514008111","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514008111?lang=zh_cn&edition=full","pubTime":"2025-02-26 13:41","pubTimestamp":1740548516,"startTime":"0","endTime":"0","summary":"2025年02月26日下午盘13时41分,嘉和生物-B股票出现波动,股价大幅上涨5.10%。截至发稿,该股报2.060港元/股,成交量61.75万股,换手率0.12%,振幅9.69%。资金方面,该股资金流入62.294万港元,流出55.844万港元。嘉和生物-B股票所在的生物技术行业中,整体涨幅为2.56%。嘉和生物-B公司简介:嘉和生物药业曼(开曼)控股有限公司是一家主要从事生物制药业务的公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502261341569630be7b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502261341569630be7b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","06998","BK1583","BK1161"],"gpt_icon":0},{"id":"2513823484","title":"嘉和生物-B盘中异动 下午盘股价大涨5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2513823484","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2513823484?lang=zh_cn&edition=full","pubTime":"2025-02-21 14:40","pubTimestamp":1740120038,"startTime":"0","endTime":"0","summary":"2025年02月21日下午盘14时40分,嘉和生物-B股票出现波动,股价急速拉升5.00%。截至发稿,该股报1.890港元/股,成交量66.55万股,换手率0.13%,振幅5.00%。嘉和生物-B股票所在的生物技术行业中,整体涨幅为4.77%。嘉和生物-B公司简介:嘉和生物药业曼(开曼)控股有限公司是一家主要从事生物制药业务的公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250221144038988d52b8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250221144038988d52b8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","BK1161","06998","BK1583"],"gpt_icon":0},{"id":"2512566121","title":"嘉和生物-B盘中异动 下午盘大幅上涨5.33%报1.780港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512566121","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2512566121?lang=zh_cn&edition=full","pubTime":"2025-02-19 14:44","pubTimestamp":1739947464,"startTime":"0","endTime":"0","summary":"2025年02月19日下午盘14时44分,嘉和生物-B股票出现异动,股价大幅上涨5.33%。截至发稿,该股报1.780港元/股,成交量43万股,换手率0.08%,振幅8.28%。资金方面,该股资金流入40.4835万港元,流出27.9705万港元。嘉和生物-B股票所在的生物技术行业中,整体跌幅为0.20%。其相关个股中,华领医药-B、晶泰控股-P、加科思-B涨幅较大,振幅较大的相关个股有华领医药-B、北海康成-B、晶泰控股-P,振幅分别为31.18%、23.53%、18.06%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219144424988abe29&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219144424988abe29&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06998","BK1583","BK1161","BK1574"],"gpt_icon":0},{"id":"2511658753","title":"嘉和生物-B盘中异动 下午盘股价大涨5.39%","url":"https://stock-news.laohu8.com/highlight/detail?id=2511658753","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2511658753?lang=zh_cn&edition=full","pubTime":"2025-02-14 15:06","pubTimestamp":1739516781,"startTime":"0","endTime":"0","summary":"2025年02月14日下午盘15时06分,嘉和生物-B股票出现异动,股价快速拉升5.39%。截至发稿,该股报1.760港元/股,成交量9.6万股,换手率0.02%,振幅5.39%。嘉和生物-B股票所在的生物技术行业中,整体涨幅为3.34%。嘉和生物-B公司简介:嘉和生物药业曼(开曼)控股有限公司是一家主要从事生物制药业务的公司。消息层面,截至15时06分,《困境中的转机——嘉和生物与亿腾医药合并》资讯为影响嘉和生物-B的重要信息。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021415062298850ee5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021415062298850ee5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1574","BK1583","06998"],"gpt_icon":0},{"id":"2511638680","title":"困境中的转机——嘉和生物与亿腾医药合并","url":"https://stock-news.laohu8.com/highlight/detail?id=2511638680","media":"新浪财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2511638680?lang=zh_cn&edition=full","pubTime":"2025-02-14 12:04","pubTimestamp":1739505882,"startTime":"0","endTime":"0","summary":"2024年10月7日,港股18A公司嘉和生物发布公告,宣布与亿腾医药订立合并协议,亿腾医药将反向并购嘉和生物,合并后的新公司名称预计将改为“亿腾嘉和”。此次合并亿腾医药,将使得嘉和生物能够借助亿腾医药强大的商业化能力,将手中的创新药物更快地推向市场,实现商业化收益。当然嘉和生物与亿腾医药的合并事件也为我们留下了许多值得思考的地方:企业应该如何根据自身优势和市场环境,制定出合适的发展战略?","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214122036abce64bf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214122036abce64bf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["09939","BK1583","BK1574","06998","BK1515","BK1161"],"gpt_icon":0},{"id":"1174803964","title":"异动解读 | 嘉和生物-B拟更换核数师 股价盘中大跌5.35%","url":"https://stock-news.laohu8.com/highlight/detail?id=1174803964","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1174803964?lang=zh_cn&edition=full","pubTime":"2025-01-23 14:20","pubTimestamp":1737613248,"startTime":"0","endTime":"0","summary":"嘉和生物-B(06998.HK)今日股价在港交所盘中大跌5.35%,引起市场关注。\n消息面上,嘉和生物公布拟罢免罗兵咸永道会计师事务所,改聘安永作为新的核数师。该决定主要基于公司无法就最新一个财政年度的审计时间表与罗永达成共识。\n公司此举旨在继续维持审计质素,符合公司及股东整体利益。但此类更换核数师的决定,往往会令投资者对公司财务状况和企业管治产生担忧,因而成为导致该公司股价今日大跌的主要原因。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"异动解读 | 嘉和生物-B拟更换核数师 股价盘中大跌5.35%","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["06998"],"gpt_icon":0},{"id":"2505566880","title":"嘉和生物-B盘中异动 急速下跌5.35%报1.770港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2505566880","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2505566880?lang=zh_cn&edition=full","pubTime":"2025-01-23 14:18","pubTimestamp":1737613107,"startTime":"0","endTime":"0","summary":"2025年01月23日下午盘14时18分,嘉和生物-B股票出现波动,股价急速跳水5.35%。截至发稿,该股报1.770港元/股,成交量13.3万股,换手率0.03%,振幅6.42%。资金方面,该股资金流入8.8745万港元,流出8.133万港元。嘉和生物-B股票所在的生物技术行业中,整体涨幅为0.09%。其相关个股中,华康生物医学、永泰生物-B、正大企业国际涨幅较大,振幅较大的相关个股有华康生物医学、永泰生物-B、正大企业国际,振幅分别为33.33%、16.60%、15.33%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250123141827960dbe1b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250123141827960dbe1b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","BK1161","06998","BK1583"],"gpt_icon":0},{"id":"2505864180","title":"嘉和生物(06998.HK)拟罢免罗兵咸永道 改聘安永为新核数师","url":"https://stock-news.laohu8.com/highlight/detail?id=2505864180","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2505864180?lang=zh_cn&edition=full","pubTime":"2025-01-23 08:14","pubTimestamp":1737591240,"startTime":"0","endTime":"0","summary":"嘉和生物-B公布,未能就截至2024年12月31日止财政年度的审计时间表,与公司核数师罗兵咸永道达成共识。在考虑有关事实及情况后,审核委员会已向董事会建议,就建议罢免罗兵咸永道寻求公司股东批准。另外,董事会根据审核委员会的建议已作出决议,提议股东批准委任安永为新核数师,以填补罢免罗兵咸永道后产生的临时空缺,任期至公司下一届股东周年大会结束为止。","market":"fut","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20210316101710780_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20210316101710780_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1412611/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1161","06998","BK1574","BK1583"],"gpt_icon":0},{"id":"2505724517","title":"嘉和生物-B拟委任安永为新核数师","url":"https://stock-news.laohu8.com/highlight/detail?id=2505724517","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2505724517?lang=zh_cn&edition=full","pubTime":"2025-01-22 22:57","pubTimestamp":1737557822,"startTime":"0","endTime":"0","summary":"格隆汇1月22日丨嘉和生物-B(06998.HK)公告,公司拟于公司将召开及举行的股东特别大会上通过相关决议案后罢免罗兵咸永道会计师事务所(\"罗兵咸永道\")的公司核数师一职。董事会提议委任安永会计师事务所(\"安永\")为公司的新核数师,以填补因建议罢免而产生的临时空缺,任期至公司下届股东周年大会结束为止。【免责声明】本文仅代表作者本人观点,与和讯网无关。和讯网站对文中陈述、观点判断保持中立,不对所包含内容的准确性、可靠性或完整性提供任何明示或暗示的保证。请读者仅作参考,并请自行承担全部责任。邮箱:news_center@staff.hexun.com","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250122230241986f7da8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250122230241986f7da8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","BK1574","06998","BK1161"],"gpt_icon":0},{"id":"2505294577","title":"【嘉和生物-B:拟委任安永为新核数师】嘉和生物-B公告,公司拟于公司将召开及举行的股东特别大会上通过相关决议案后罢免罗兵咸永道会计师事务所的公司核数师一职。董事会提议委任安永会计师事务所为公司的新核数师,以填补因建议罢免而产生的临时空缺,任期至公司下届股东周年大会结束为止。","url":"https://stock-news.laohu8.com/highlight/detail?id=2505294577","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2505294577?lang=zh_cn&edition=full","pubTime":"2025-01-22 22:56","pubTimestamp":1737557778,"startTime":"0","endTime":"0","summary":"嘉和生物-B公告,公司拟于公司将召开及举行的股东特别大会上通过相关决议案后罢免罗兵咸永道会计师事务所的公司核数师一职。董事会提议委任安永会计师事务所为公司的新核数师,以填补因建议罢免而产生的临时空缺,任期至公司下届股东周年大会结束为止。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/01/22225647722763.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK1583","BK1161","06998","BK1574"],"gpt_icon":0},{"id":"2505725462","title":"【嘉和生物-B(06998.HK)拟委任安永会计师事务所为新核数师】嘉和生物-B(06998.HK)发布公告,公司拟于公司将召开及举行的股东特别大会上通过相关决议案后罢免罗兵咸永道会计师事务所的公司核数师一职。","url":"https://stock-news.laohu8.com/highlight/detail?id=2505725462","media":"金融界","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2505725462?lang=zh_cn&edition=full","pubTime":"2025-01-22 22:29","pubTimestamp":1737556165,"startTime":"0","endTime":"0","summary":"嘉和生物-B(06998.HK)发布公告,公司拟于公司将召开及举行的股东特别大会上通过相关决议案后罢免罗兵咸永道会计师事务所的公司核数师一职。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/01/22222947722447.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK1161","BK1583","06998","BK1574"],"gpt_icon":0},{"id":"2505614725","title":"嘉和生物-B(06998)拟委任安永会计师事务所为新核数师","url":"https://stock-news.laohu8.com/highlight/detail?id=2505614725","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2505614725?lang=zh_cn&edition=full","pubTime":"2025-01-22 22:26","pubTimestamp":1737555990,"startTime":"0","endTime":"0","summary":"智通财经APP讯,嘉和生物-B(06998)发布公告,公司拟于公司将召开及举行的股东特别大会上通过相关决议案后罢免罗兵咸永道会计师事务所的公司核数师一职。经公司审核委员会建议,待建议罢免于股东特别大会上通过普通决议案生效后,董事会提议委任安永会计师事务所为公司的新核数师,以填补因建议罢免而产生的临时空缺,任期至公司下届股东周年大会结束为止。建议委任须待(其中包括)于股东特别大会上通过相关决议案后,方可作实。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1242226.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["06998","BK1161","BK1583","BK1574"],"gpt_icon":0},{"id":"2502050283","title":"嘉和生物-B盘中异动 下午盘股价大涨5.41%报1.950港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2502050283","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2502050283?lang=zh_cn&edition=full","pubTime":"2025-01-09 13:46","pubTimestamp":1736401572,"startTime":"0","endTime":"0","summary":"2025年01月09日下午盘13时46分,嘉和生物-B股票出现异动,股价快速上涨5.41%。截至发稿,该股报1.950港元/股,成交量6.6万股,换手率0.01%,振幅7.03%。资金方面,该股资金流入8.6055万港元,流出1.2045万港元。嘉和生物-B股票所在的生物技术行业中,整体涨幅为1.31%。嘉和生物-B公司简介:嘉和生物药业曼(开曼)控股有限公司是一家主要从事生物制药业务的公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250109134613aba41ac5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250109134613aba41ac5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","BK1583","06998","BK1161"],"gpt_icon":0},{"id":"1100323711","title":"异动解读 | 嘉和生物-B(06998)盘中大涨逾9% 公司与亿腾医药达成反向合并协议","url":"https://stock-news.laohu8.com/highlight/detail?id=1100323711","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1100323711?lang=zh_cn&edition=full","pubTime":"2025-01-02 12:02","pubTimestamp":1735790557,"startTime":"0","endTime":"0","summary":"嘉和生物-B今日盘中大涨9.83%,报1.9港元,成交额183.56万港元。近日,嘉和生物与亿腾医药宣布达成合并协议。根据协议,亿腾医药将以反向收购的方式,成为嘉和生物的全资附属公司,并更名为\"亿腾嘉和医药集团有限公司\"。市场对于此次合并有利于释放双方潜力的看好预期,是推动嘉和生物股价大涨的主因。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["06998"],"gpt_icon":0},{"id":"2500993539","title":"港股异动 | 嘉和生物-B(06998)逆市涨近10% 近日与亿腾医药宣布达成战略合并协议","url":"https://stock-news.laohu8.com/highlight/detail?id=2500993539","media":"智通财经","labels":["corporation","movement"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2500993539?lang=zh_cn&edition=full","pubTime":"2025-01-02 11:55","pubTimestamp":1735790149,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,嘉和生物-B逆市涨近10%。消息面上,近日,嘉和生物与亿腾医药宣布达成合并协议。据了解,通过整合嘉和生物的创新研发资源,亿腾医药将能够加速创新药物的研发和市场推广。除了在国内市场发力外,嘉和生物与亿腾医药还将目光投向了海外市场。嘉和生物与亿腾医药的合并,将为双方未来的海外市场拓展奠定坚实的基础。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1232302.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["09939","BK1583","BK1574","159938","06998","BK1515","BK1161"],"gpt_icon":0},{"id":"2500967964","title":"嘉和生物-B盘中异动 股价大涨5.20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2500967964","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2500967964?lang=zh_cn&edition=full","pubTime":"2025-01-02 10:46","pubTimestamp":1735785962,"startTime":"0","endTime":"0","summary":"2025年01月02日早盘10时46分,嘉和生物-B股票出现波动,股价大幅拉升5.20%。截至发稿,该股报1.820港元/股,成交量58.1万股,换手率0.11%,振幅5.20%。嘉和生物-B股票所在的生物技术行业中,整体跌幅为0.30%。其相关个股中,华康生物医学、歌礼制药-B、思路迪医药股份涨幅较大,振幅较大的相关个股有华康生物医学、华昊中天医药-B、歌礼制药-B,振幅分别为29.33%、20.81%、13.62%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250102104602ab9b29c4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250102104602ab9b29c4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","06998","BK1574","BK1583"],"gpt_icon":0}],"profile":{"stockEarnings":[{"period":"1week","weight":0.0187},{"period":"1month","weight":0.1354},{"period":"3month","weight":0.3133},{"period":"6month","weight":0.3212},{"period":"1year","weight":0.8793},{"period":"ytd","weight":0.2601}],"compareEarnings":[{"period":"1week","weight":-0.0564},{"period":"1month","weight":-0.0057},{"period":"3month","weight":0.1615},{"period":"6month","weight":0.1716},{"period":"1year","weight":0.4171},{"period":"ytd","weight":0.1637}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"嘉和生物药业(开曼)控股有限公司是一家主要从事生物制药产品研发的中国公司。该公司专注于开发及商业化肿瘤学及自身免疫性疾病。该公司的主要的药物包括lerociclib(GB491)、coprelotamab(GB221)、geptanolimab(GB226)、GB492、GB242以及GB223。该公司主要于中国市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.6,"avgChangeRate":-0.050516},{"month":2,"riseRate":0.4,"avgChangeRate":-0.004657},{"month":3,"riseRate":0.6,"avgChangeRate":0.033795},{"month":4,"riseRate":0.25,"avgChangeRate":-0.147203},{"month":5,"riseRate":0.5,"avgChangeRate":-0.020922},{"month":6,"riseRate":0.75,"avgChangeRate":0.079153},{"month":7,"riseRate":0.25,"avgChangeRate":-0.144734},{"month":8,"riseRate":0.25,"avgChangeRate":-0.022403},{"month":9,"riseRate":0.5,"avgChangeRate":-0.083889},{"month":10,"riseRate":0.5,"avgChangeRate":-0.003872},{"month":11,"riseRate":0.2,"avgChangeRate":-0.044191},{"month":12,"riseRate":0.8,"avgChangeRate":0.080331}],"exchange":"SEHK","name":"嘉和生物-B","nameEN":"GENOR-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.32.1","shortVersion":"4.32.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"嘉和生物-B(06998)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供嘉和生物-B(06998)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"嘉和生物-B,06998,嘉和生物-B股票,嘉和生物-B股票老虎,嘉和生物-B股票老虎国际,嘉和生物-B行情,嘉和生物-B股票行情,嘉和生物-B股价,嘉和生物-B股市,嘉和生物-B股票价格,嘉和生物-B股票交易,嘉和生物-B股票购买,嘉和生物-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"嘉和生物-B(06998)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供嘉和生物-B(06998)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}